These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8667857)

  • 1. Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.
    Clarke BF; Campbell IW
    Lancet; 1975 Feb; 1(7901):246-8. PubMed ID: 8667857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
    Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P; Oksala H; Pitkäjärvi T
    Arzneimittelforschung; 1985; 35(10):1596-9. PubMed ID: 3935120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet.
    Clarke BF; Campbell IW
    Br Med J; 1977 Dec; 2(6102):1576-8. PubMed ID: 589351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorpropamide-induced hyponatremia: incidence and risk factors.
    Kadowaki T; Hagura R; Kajinuma H; Kuzuya N; Yoshida S
    Diabetes Care; 1983; 6(5):468-71. PubMed ID: 6443808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.
    Chan TY; Cheung AY
    Age Ageing; 1997 Sep; 26(5):409-10. PubMed ID: 9351488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
    Aiello C; Turner D; Aparicio NJ; De Turner EA; Vazquez A
    Acta Diabetol Lat; 1973; 10(1):30-53. PubMed ID: 4197367
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Treatment of maturity-onset diabetes.
    Clarke BF; Campbell IW
    Lancet; 1975 Mar; 1(7906):580-1. PubMed ID: 47059
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.
    Sönksen PH; Lowy C; Perkins JR; West TE
    Diabetologia; 1981; 20(1):22-30. PubMed ID: 6781962
    [No Abstract]   [Full Text] [Related]  

  • 12. The 24-hour effects of glyburide and chlorpropamide after chronic treatment of type II diabetic patients.
    Prosser PR; Kosola JW; Bowers CY
    Am J Med Sci; 1985 May; 289(5):179-85. PubMed ID: 3923833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of glyburide in diabetics poorly controlled on first-generation oral hypoglycemics.
    Cohen KL; Harris S
    Diabetes Care; 1987; 10(5):555-7. PubMed ID: 3119302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.
    Harrower AD
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S65-7. PubMed ID: 1794268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Treatment of maturity-onset diabetes.
    Luntz GR
    Lancet; 1975 Mar; 1(7909):743. PubMed ID: 47501
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.